Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes

Key Points

• The aim is to evaluate the effectiveness of voice-based AI in managing basal insulin prescriptions for individuals with type 2 diabetes.
• Randomized trial of patients with type 2 diabetes utilizing voice-based AI for insulin management.
• ClinicalTrials.gov Identifier: NCT05081011.
• Improvements in insulin management efficiency were observed among patients using the voice-based AI.
• Further quantitative results are pending publication.